Cosmo BIO Company FY2026/12 Q2 Earnings Forecast Upward Revision

TOKYO, Jul 24 (Pulse News Wire) – COSMO BIO COMPANY,LIMITED (3386) has revised its FY2026/12 Q2 consolidated earnings forecast. FORECAST REVISION SUMMARY: (Unit: millions of yen) Revenue Op Profit Ord Profit Net Profit Previous Forecast (A) 5,700 170 200 130 Revised Forecast (B) 5,914 279 340 277 Change (B-A) 214 109 140 147 Change (%): Revenue +3.8% | OP +64.5% | OrdP +70.2% | NP +113.3% Prior Year Actual 5,402 276 343 250 KEY CHANGES: - Revenue forecast raised by +3.8% to 5,914 - Net profit forecast raised by +113.3% to 277 - Operating profit forecast raised by +64.5% to 279